Pediatrix Medical Group — Q3 2026 Earnings Summary

Pediatrix Medical Group reported third-quarter 2026 net revenue of $501.4 million and net income of $47.0 million, or $0.59 per diluted share. Adjusted EBITDA for the quarter was $85.5 million, while Adjusted EPS reached $0.72. For the nine months ended September 30, 2026, the company generated $1.47 billion in revenue and $116.4 million in net income, with Adjusted EBITDA totaling $220.1 million. The company anticipates full-year 2026 Adjusted EBITDA to fall between $290 million and $300 million.